Could authorization for off-label use be beneficial to the Brazilian Unified National Health System?

被引:0
|
作者
Santos, Marisa da Silva [1 ,6 ]
da Costa, Marcia Gisele Santos [1 ]
Tura, Bernardo Rangel [1 ]
Torres, Priscila [2 ,3 ]
Martins, Sandro Jose [4 ]
Toscas, Fotini Santos [5 ]
机构
[1] Inst Nacl Cardiol, Rio De Janeiro, Brazil
[2] Conselho Nacl Saude, Brasilia, Brazil
[3] Biored Brasil, Brasilia, Brazil
[4] Hosp Univ Brasilia, Brasilia, Brazil
[5] Secretaria Estado Saude Sao Paulo, Inst Saude, Sao Paulo, Brazil
[6] Inst Nacl Cardiol, Rua Laranjeiras 374, BR-22240006 Rio De Janeiro, RJ, Brazil
来源
CADERNOS DE SAUDE PUBLICA | 2023年 / 39卷 / 06期
关键词
D O I
10.1590/0102-311XPT032623
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [1] Authorization for off-label use may not be beneficial for the Brazilian Unified National Health System
    Caetano, Rosangela
    Lopes, Luciane Cruz
    Santos, Gustavo Mendes Lima
    Osorio-de-Castro, Claudia Garcia Serpa
    CADERNOS DE SAUDE PUBLICA, 2023, 39 (06):
  • [3] Off-label use of antipsychotics: Rethinking "off-label"
    Groleger, Urban
    PSYCHIATRIA DANUBINA, 2007, 19 (04) : 350 - 353
  • [4] National Trends in Pediatric Use of Anticonvulsants: On and Off-Label
    Tran, Allen R.
    Julie, Zito M.
    Daniel, Safer J.
    Sarah, Hundley
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S321 - S322
  • [5] Off-label use in cardiac surgery ["Off-label use" in der Herzchirurgie]
    Fenger H.
    Löher A.
    Sindermann J.R.
    Scheld H.H.
    Schmidt C.
    Hoffmeier A.
    Zeitschrift für Herz-,Thorax- und Gefäßchirurgie, 2009, 23 (6) : 345 - 348
  • [6] "OFF-LABEL" USE OF COMMON MEDICINES COULD TARGET THE VULVODYNIA MECHANISM
    Falsetta, M.
    Flores, B.
    Fischer, S.
    Bekauri, T.
    Maddipati, K. R.
    Honn, K.
    Haidaris, C.
    Foster, D.
    Wood, R.
    JOURNAL OF SEXUAL MEDICINE, 2022, 19 (08): : S1 - S1
  • [7] Evaluation of off-label rapamycin use on oral health
    Hudson, Johnny
    Kaeberlein, Tammi
    Mahal, Akashdeep
    Wong, Nelson
    Ghorbanifarajzadeh, Mina
    Radella, Frank
    Isman, Anar
    Nyquist, Andy
    Zalzala, Sajad
    Haddad, George
    Kaeberlein, Matt
    An, Jonathan Y.
    GEROSCIENCE, 2024, : 4135 - 4146
  • [8] Off-label use and G-BA. Legal framework for off-label use
    Brucklacher, U.
    Brockmeyer, N. H.
    Riedel, C.
    HAUTARZT, 2013, 64 (10): : 736 - 742
  • [9] Use of unlicensed and off-label drugs in neonates in a Brazilian university hospital
    de Souza Goncalves, Adriana Cristina
    Moreira Reis, Adriano Max
    Gusmao Marcal, Ana Carolina
    Ferrarez Bouzada, Maria Candida
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 53 (03)
  • [10] Off-Label Antidepressant Use
    Schaefer, Wiebke
    Kollhorst, Bianca
    Reinders, Tammo
    Riedel, Oliver
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 465 - 466